ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $298,000 | -55.5% | 6,375 | -65.7% | 0.03% | -60.5% |
| Q2 2017 | $669,000 | +17.0% | 18,584 | 0.0% | 0.08% | +35.7% |
| Q1 2017 | $572,000 | -51.4% | 18,584 | -65.2% | 0.06% | -64.1% |
| Q2 2016 | $1,178,000 | -53.0% | 53,415 | -37.3% | 0.16% | -48.5% |
| Q1 2016 | $2,504,000 | +95.2% | 85,258 | +119.5% | 0.30% | +89.4% |
| Q4 2015 | $1,283,000 | +6.3% | 38,843 | +16.3% | 0.16% | -2.4% |
| Q3 2015 | $1,207,000 | -16.2% | 33,400 | +4.4% | 0.16% | -33.1% |
| Q2 2015 | $1,440,000 | +372.1% | 32,000 | +221.5% | 0.24% | +202.5% |
| Q1 2015 | $305,000 | – | 9,954 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |